FAC Conference

The FAC Conference, hosted at the picturesque Mantra on Salt Beach in Kingscliff, Australia, is set to be a premier gathering for health professionals focusing on familial and population-based cancer research. This event is organized by the University of Cambridge and aims to foster knowledge sharing and collaboration among a … Read More diverse range of professionals, including medical oncologists, surgeons, genetic counselors, cancer specialists, and researchers from Australia and New Zealand. Attendees will have the opportunity to engage in rich discussions that span new research findings, clinical trials, and innovative technologies addressing various familial cancer syndromes. Key topics will include breast, ovarian, prostate, endometrial, melanoma, sarcoma, leukaemia, and colorectal cancers, along with novel research initiatives such as Polygenic Risk Score and cancer risk assessment, advanced Long Read Sequencing techniques for variant detection, early cancer detection programs, and the implications of precision medicine and cancer genetics in diverse populations.

The conference will feature a hybrid format that allows participants to choose between attending in person or online, ensuring accessibility for all. Attendees can look forward to a comprehensive FAC experience, which includes keynote presentations from renowned speakers such as Professor Charles Swanton from The Francis Crick Institute, and other distinguished professionals like Dr. Yurgelun and Katianne Howard Sharp from the Children’s Cancer Institute. Networking events, opportunities for presenting oral or poster abstracts, and a dynamic industry exhibition will also be integral parts of the agenda. The collaborative efforts of the FAC organizing committee, in partnership with Inherited Cancers Australia, highlight a commitment to consumer advocacy and representation within the program. This conference promises valuable insights, connections, and opportunities for all participants, making it a significant event in the field of cancer research.